헬스케어 BI : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, Healthcare business intelligence market size in 2026 is estimated at USD 13.29 billion, growing from 2025 value of USD 11.64 billion with 2031 projections showing USD 25.79 billion, growing at 14.18% CAGR over 2026-2031.

This report Segments the Industry Into by Component (Software, Services), by Mode of Delivery (On-Premise Model, Hybrid Model, Cloud-Based Model), by Application (Financial Analysis, Clinical Data Analysis and More), by End User (Payers, Healthcare Providers, Other End Users), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Healthcare BI Market Trends and Insights

Regulatory Push for Value-Based Reimbursement

Policies linking payments to outcomes are now mainstream. The Centers for Medicare & Medicaid Services intends to place all Medicare beneficiaries in accountable care relationships by 2030, a goal echoing across commercial payers. Organizations require near real-time analytics that synthesize clinical, financial, and social-determinant data to manage at-risk populations and predict performance under complex contracts. Health systems such as Carle Health have cut avoidable costs while boosting quality by integrating claims, EHR, and social-risk data in their BI stack. As every payment model embeds risk, demand for platforms capable of continuous measurement and predictive modeling will intensify.

Rising EHR Data Volume & Interoperability Mandates

Epic's Cosmos now aggregates de-identified records from 246 million individuals, illustrating the unprecedented scale of healthcare data. The 21st Century Cures Act and TEFCA oblige providers to share information, yet less than 60% of available data informs decision-making because of fragmentation. Adoption of Fast Healthcare Interoperability Resources (FHIR) streams data in near real time, laying a technical foundation for advanced analytics. Tackling data quality, standardization, and governance remains essential as volumes soar.

Data Silos & Legacy Interoperability Gaps

Disconnected systems delay care and inflate costs despite FHIR and Cures Act mandates. Many hospitals still grapple with proprietary data formats and aging architectures that block enterprise-wide analytics. Competitive concerns and privacy rules further slow data-sharing outside organizational walls. Overcoming silos will require continued investment in integration engines, master-data management, and cultural change.

Other drivers and restraints analyzed in the detailed report include:

1. Cloud Cost-Efficiencies Enabling Analytics at Scale
2. AI-Led Automated Insight Generation (Gen-AI)
3. High Total Cost of Ownership for Enterprise BI

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Software held the largest 35.02% share of the healthcare business intelligence market in 2025, anchored by analytics suites, visualization dashboards, and embedded AI services. However, services-covering integration, training, and managed analytics-are expanding at a 14.52% CAGR, outpacing platform sales. This divergence signals that value lies not just in owning tools but in operationalizing them within complex clinical workflows.

Organizations rely on external experts to migrate legacy data, customize dashboards, and coach users. The acute shortage of data-literate clinicians sustains services demand. Epic's move into enterprise resource planning underscores that large platform vendors now package consulting to accelerate adoption. As systems mature, services partners will manage ongoing data governance, performance tuning, and algorithm validation, reinforcing their role as critical enablers of analytic ROI.

OLAP & visualization accounted for 40.88% of 2025 revenue, offering intuitive dashboards for day-to-day monitoring across finance, quality, and compliance. Yet advanced & predictive analytics is projected to grow 15.01% annually as providers pursue proactive care.

Health Catalyst clients have saved millions through early detection algorithms and risk stratification models. Generative AI further lowers the barrier to sophisticated modeling by automating feature engineering and scenario testing. Microsoft's USD 13 billion AI run rate illustrates demand for packaged frameworks that embed machine learning into the analytic fabric. As algorithms mature, organizations will transition from retrospective reporting toward prospective intervention planning in population health and precision medicine.

Complete Report Scope:

• By Component
  • Platforms
  • Software
  • Services
• By Function
  • OLAP & Visualisation
  • Performance Management
  • Query & Reporting
  • Advanced & Predictive Analytics
• By Application
  • Clinical Analytics
    • Population Health Management
    • Precision Medicine Support
    • Quality & Outcome Improvement
  • Financial Analytics
    • Revenue Cycle Management
    • Fraud Detection & Risk Adjustment
  • Operational Analytics
    • Supply-Chain & Inventory Optimisation
    • Staffing & Workflow Optimisation
  • Strategic Planning & Benchmarking
• By End User
  • Healthcare Providers
    • Hospitals & Health Systems
    • Ambulatory Surgical Centres
    • Specialty Clinics
  • Payers
    • Public Payers
    • Private Payers
  • Life-Science Companies
  • Government & Public-Health Agencies
  • Other End Users (ACOs, CROs)
• By Region
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middel East and Africa

Geography Analysis

North America led with a 45.97% share of the healthcare business intelligence market in 2025, fueled by mature EHR penetration, mandated interoperability, and early adoption of value-based care. Epic's base of more than 325 million patient records entrenches its influence on regional data flows. Legislative clarity, coupled with robust cloud infrastructure, speeds enterprise analytics rollouts. Anticipated pro-business policies may accelerate private-equity activity, intensifying competition and innovation in BI tooling.

Asia-Pacific is the fastest-growing region at a 16.61% CAGR to 2031, reflecting aggressive national digital-health plans and rising healthcare spending. India's insurance-funded models demand population-health insights, while Singapore integrates IoT devices for preventive monitoring. Governments in China, Australia, and Thailand fund AI pilots to manage chronic-disease burdens amid aging populations. Even developing markets are leapfrogging legacy systems by adopting cloud-native platforms, creating outsized opportunities for scalable BI vendors.

Europe shows steady expansion as GDPR drives investment in compliant data governance and cross-border interoperability. Programs like the European Health Data Space encourage standardized analytics across member states, boosting vendor opportunities. Middle East and Africa, though starting from lower bases, invest heavily in EHRs and telemedicine, especially in Gulf Cooperation Council nations. Modernization initiatives align with the need to benchmark quality outcomes, suggesting a gradual rise in BI penetration.

1. Microsoft
2. IBM
3. Oracle (incl. Cerner)
4. SAP
5. Optum
6. Qlik
7. Salesforce (Tableau)
8. SAS Institute
9. Health Catalyst
10. Dimensional Insight
11. Mckesson
12. Epic Systems
13. Inovalon
14. MedeAnalytics
15. Veradigm (Allscripts)
16. IQVIA
17. AWS (HealthLake)
18. Google Cloud Healthcare
19. Snowflake
20. Innovaccer
21. Clarify Health
22. Arcadia

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Regulatory push for value-based reimbursement
  • 4.2.2 Rising EHR data volume & interoperability mandates
  • 4.2.3 Cloud cost-efficiencies enabling analytics at scale
  • 4.2.4 AI-led automated insight generation (Gen-AI)
  • 4.2.5 FHIR-based real-time data streaming adoption
  • 4.2.6 Availability of synthetic healthcare data sets
• 4.3 Market Restraints
  • 4.3.1 Data silos & legacy interoperability gaps
  • 4.3.2 High total cost of ownership for enterprise BI
  • 4.3.3 Shortage of data-literate clinical staff
  • 4.3.4 Cross-border data-transfer & AI-governance risks
• 4.4 Regulatory Landscape
• 4.5 Technological Outlook
• 4.6 Porter's Five Forces
  • 4.6.1 Threat of New Entrants
  • 4.6.2 Bargaining Power of Suppliers
  • 4.6.3 Bargaining Power of Buyers
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD Billion)

• 5.1 By Component
  • 5.1.1 Platforms
  • 5.1.2 Software
  • 5.1.3 Services
• 5.2 By Function
  • 5.2.1 OLAP & Visualisation
  • 5.2.2 Performance Management
  • 5.2.3 Query & Reporting
  • 5.2.4 Advanced & Predictive Analytics
• 5.3 By Application
  • 5.3.1 Clinical Analytics
    • 5.3.1.1 Population Health Management
    • 5.3.1.2 Precision Medicine Support
    • 5.3.1.3 Quality & Outcome Improvement
  • 5.3.2 Financial Analytics
    • 5.3.2.1 Revenue Cycle Management
    • 5.3.2.2 Fraud Detection & Risk Adjustment
  • 5.3.3 Operational Analytics
    • 5.3.3.1 Supply-Chain & Inventory Optimisation
    • 5.3.3.2 Staffing & Workflow Optimisation
  • 5.3.4 Strategic Planning & Benchmarking
• 5.4 By End User
  • 5.4.1 Healthcare Providers
    • 5.4.1.1 Hospitals & Health Systems
    • 5.4.1.2 Ambulatory Surgical Centres
    • 5.4.1.3 Specialty Clinics
  • 5.4.2 Payers
    • 5.4.2.1 Public Payers
    • 5.4.2.2 Private Payers
  • 5.4.3 Life-Science Companies
  • 5.4.4 Government & Public-Health Agencies
  • 5.4.5 Other End Users (ACOs, CROs)
• 5.5 By Region
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 South America
    • 5.5.2.1 Brazil
    • 5.5.2.2 Argentina
    • 5.5.2.3 Rest of South America
  • 5.5.3 Europe
    • 5.5.3.1 Germany
    • 5.5.3.2 United Kingdom
    • 5.5.3.3 France
    • 5.5.3.4 Italy
    • 5.5.3.5 Spain
    • 5.5.3.6 Russia
    • 5.5.3.7 Rest of Europe
  • 5.5.4 Asia-Pacific
    • 5.5.4.1 China
    • 5.5.4.2 Japan
    • 5.5.4.3 India
    • 5.5.4.4 South Korea
    • 5.5.4.5 Australia
    • 5.5.4.6 Rest of Asia-Pacific
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 GCC
    • 5.5.5.2 South Africa
    • 5.5.5.3 Rest of Middel East and Africa

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Competitive Benchmarking
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.4.1 Microsoft
  • 6.4.2 IBM
  • 6.4.3 Oracle (incl. Cerner)
  • 6.4.4 SAP SE
  • 6.4.5 Optum
  • 6.4.6 Qlik
  • 6.4.7 Salesforce (Tableau)
  • 6.4.8 SAS Institute
  • 6.4.9 Health Catalyst
  • 6.4.10 Dimensional Insight
  • 6.4.11 McKesson
  • 6.4.12 Epic Systems
  • 6.4.13 Inovalon
  • 6.4.14 MedeAnalytics
  • 6.4.15 Veradigm (Allscripts)
  • 6.4.16 IQVIA
  • 6.4.17 AWS (HealthLake)
  • 6.4.18 Google Cloud Healthcare
  • 6.4.19 Snowflake
  • 6.4.20 Innovaccer
  • 6.4.21 Clarify Health
  • 6.4.22 Arcadia

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment